Diabetes and Hypertension
Diabetes and Hypertension
Part of NephTimes Diseases and Conditions
Advertisement
Charlotte RobinsonDiabetes and Hypertension | September 24, 2024
Having a precise estimation of the costs incurred by DKD patients is an important step in finding ways to contain such costs.
Read More
Charlotte RobinsonDiabetes and Hypertension | September 18, 2024
What is the relationship between blood urea nitrogen-to-serum albumin ratio and mortality in ICU patients with T2D and CKD?
Charlotte RobinsonDiabetes and Hypertension | August 26, 2024
A study examined the association between consuming different meats and the odds of developing kidney damage and DN.
Charlotte RobinsonDiabetes and Hypertension | August 23, 2024
Researchers tried to determine whether eGFR slope is a predictor of type 2 diabetes complications.
Charlotte RobinsonDiabetes and Hypertension | September 18, 2024
A study examined the association of HbA1c with mortality in patients with chronic kidney disease and type 2 diabetes.
Charlotte RobinsonDiabetes and Hypertension | June 28, 2024
Researchers conducted an analysis to quantify the within-individual variability of albuminuria in patients with T2D.
Charlotte RobinsonDiabetes and Hypertension | June 7, 2024
A survey found that US physicians would like to find new approaches to lowering patients' blood pressure.
Victoria SochaDiabetes and Hypertension | May 14, 2024
Could urinary podocyte stress biomarker be a surrogate marker of podocyte injury in diabetic kidney disease (DKD)?
Victoria SochaChronic Kidney Disease | May 9, 2024
There are few data on whether finerenone-induced change in UACR mediates cardiovascular and kidney failure outcomes.
Victoria SochaIgA Nephropathy | May 2, 2024
Researchers studied the effect of intensive blood pressure control on the progression of IgAN. 
Charlotte RobinsonChronic Kidney Disease | May 1, 2024
Researchers explored the association between CSVD and CKD plus the potential role of hypertension in this association.
Charlotte RobinsonDiabetes and Hypertension | May 2, 2024
Researchers examined use of clinical decision support systems to decrease blood pressure in hypertensive patients with CKD.
Freely FilteredNephrology Times | April 22, 2024
We've all been guilted into ordering inpatient blood pressure meds. Tim Anderson, MD, asks, "Why?"
Charlotte RobinsonChronic Kidney Disease | April 15, 2024
Kavita Mistry and Marcelle Tuttle will be the American Kidney Fund 2024 Clinical Scientist in Nephrology Fellows.
Charlotte RobinsonDiabetes and Hypertension | April 1, 2024
SGLT-2is are associated with reduced risk of mortality in patients with type 2 diabetes and acute kidney disease.
Charlotte RobinsonDiabetes and Hypertension | March 29, 2024
Medicare Part D spending on GLP-1 drugs has soared to $5.7 billion, straining Medicare spending.
Charlotte RobinsonDiabetes and Hypertension | March 29, 2024
Current practice guidelines do not address dietary management specific to diabetic kidney disease (DKD).
Charlotte RobinsonDiabetes and Hypertension | March 8, 2024
AstraZeneca has removed tozorakimab from its phase 2 pipeline for diabetic kidney disease.
Victoria SochaDiabetes and Hypertension | February 5, 2024
Patients with diabetic kidney disease face increased risk of end-stage kidney disease and dialysis.
Victoria SochaDiabetes and Hypertension | February 5, 2024
Albuminuria, hypertension, declining kidney function, and an increase in cardiovascular risk are all hallmarks of DKD.
Advertisement
Advertisement
Advertisement
Latest News

October 7, 2024